Deep vein thrombosis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Value of screening== | ==Value of screening== | ||
In-spite of identifying patients at increased risk of VTE, there is no clear clinical value for screening, the following reason explains | |||
* The strongest risk factor for VTE recurrence is the prior VTE event itself. | *The strongest risk factor for VTE recurrence is the prior VTE event itself. | ||
* | *After discontinuation of warfarin in VTE patients, especially where the cause was unknown, There are at high risk of recurrence. irrespective of the presence of inherited thrombophilia. | ||
*Anticoagulant prophylaxis is rarely recommended in asymptomatic affected family members outside of high risk situations. | *Anticoagulant prophylaxis is rarely recommended in asymptomatic affected family members outside of high risk situations. | ||
Revision as of 14:39, 24 August 2011
Value of screening
In-spite of identifying patients at increased risk of VTE, there is no clear clinical value for screening, the following reason explains
- The strongest risk factor for VTE recurrence is the prior VTE event itself.
- After discontinuation of warfarin in VTE patients, especially where the cause was unknown, There are at high risk of recurrence. irrespective of the presence of inherited thrombophilia.
- Anticoagulant prophylaxis is rarely recommended in asymptomatic affected family members outside of high risk situations.